INVIVOGEN – Trademark Portfolio

Entity Type: 34

INVIVOGEN holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ZEOCIN, NORMOCIN, PRIMOCIN, MYCOSTRIP, and PLASMOCIN.

5 rue Jean Rodier

F-31400 TOULOUSE

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

INVIVOGEN's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (9 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does INVIVOGEN have?

INVIVOGEN has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 cancelled.

What trademark classes does INVIVOGEN file in?

INVIVOGEN files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are INVIVOGEN's most well-known trademarks?

INVIVOGEN's registered trademark portfolio includes well-known marks such as ZEOCIN, NORMOCIN, PRIMOCIN, MYCOSTRIP, and PLASMOCIN. These are among 6 currently registered trademarks in the portfolio.

What is INVIVOGEN's trademark registration success rate?

INVIVOGEN has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.